Help your eligible patients save
ALREX® (loteprednol etabonate ophthalmic suspension) 0.2% is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.
Click here for Prescribing Information for ALREX.
Please choose an option below: